MENU

STOK Stoke Therapeutics Forecast, Technical & Fundamental Analysis

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

STOK is expected to report earnings to rise 14.34% to -53 cents per share on March 05

Stoke Therapeutics STOK Stock Earnings Reports
Q4'24
Est.
$-0.54
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.05
Q4'23
Beat
by $0.04
The last earnings report on November 05 showed earnings per share of -46 cents, beating the estimate of -54 cents. With 161.90K shares outstanding, the current market capitalization sits at 640.90M.
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

STOK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-1.14%
NUVB - STOK
51%
Loosely correlated
+4.46%
STRO - STOK
47%
Loosely correlated
+0.97%
INZY - STOK
46%
Loosely correlated
-2.65%
QTTB - STOK
44%
Loosely correlated
-2.00%
DNLI - STOK
42%
Loosely correlated
-0.30%
More